Table 1.
Demographic and clinical information of patients before treatment introduction
| Characteristics | GBP (Mean±SD) | DLX (Mean ± SD) | P-Value |
|---|---|---|---|
| Age (years) | 60.7±5.66 | 59.7±5.59 | 0.224 |
| Sex | |||
| Male | 21 | 24 | 0.356 |
| Female | 31 | 28 | |
| HbA1C | 8.3±1.63 | 7.8±1.96 | 0.187 |
| Duration of DM (y) | 7.86±4.28 | 8.17±4.97 | 0.784 |
| Duration DPNP (y) | 3.58±1.86 | 3.93±1.23 | 0.435 |
| Baseline VAS | 63±20.03 | 61±21.18 | 0.104 |
| Baseline sleep interference score | 7.12±1.63 | 6.86±1.57 | 0.369 |
Abbreviations: DM, Diabetes mellitus; DPNP, Diabetic peripheral neuropathic pain; DLX, Duloxetine; GBP, Gabapentin; VAS, Visual Analogue Scale.